Tempest Therapeutics, Inc. (TPST) stock

TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30

$0.38−0.00 (-0.29%)

Close on Nov 13, 2026Market cap $5.65MP/E –Yield –

Tempest Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Tempest Therapeutics's price to sales ratio was 383.1× on Jan 31, 2019, against 490.4× a year earlier.

Period	Period end	Value	Change (pts)
2019	Jan 31, 2019	383.1×	+92.5
2018	Dec 31, 2018	290.6×	−199.7
2017	Sep 29, 2017	490.4×	+134.6
2016	Dec 30, 2016	355.8×	–

See a number that looks wrong?